Merck & Co MRK
$146.73 −$0.21 (-0.14%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $146.73 0.00%
Open$144.34
Prev close$146.94
Day range$142.80 – $147.48
Volume7.63M
Market cap$361.73B
P/E (TTM)148.2
Dividend yield2.32%
Analyst view
ConsensusBuy
Analysts19
Average target$167.47+14.1% vs. price
- Buy 79%
- Hold 21%
Low $145.00Now $146.73Avg $167.47High $180.00
Recent rating changes
The last 20 actions on file set price targets from $145.00 to $180.00, averaging $164.45.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 23 Oct 2026 | Scotiabank | BUY | $180.00 |
| 22 Oct 2026 | BofA Securities | BUY | $163.00 |
| 20 Oct 2026 | RBC Capital | HOLD | $145.00 |
| 16 Oct 2026 | Goldman Sachs | BUY | $155.00 |
| 15 Oct 2026 | Wells Fargo | BUY | $165.00 |
| 12 Oct 2026 | BMO Capital | BUY | $170.00 |
| 12 Oct 2026 | Leerink Partners | BUY | $161.00 |
| 12 Oct 2026 | Barclays | BUY | $150.00 |
| 9 Oct 2026 | UBS | BUY | $175.00 |
| 9 Oct 2026 | BofA Securities | BUY | $163.00 |
| 8 Oct 2026 | Cantor Fitzgerald | HOLD | $145.00 |
| 8 Oct 2026 | BMO Capital | BUY | $170.00 |
| 7 Oct 2026 | Morgan Stanley | BUY | $177.00 |
| 5 Oct 2026 | J.P. Morgan | BUY | $165.00 |
| 30 Sep 2026 | BMO Capital | BUY | $170.00 |
| 30 Sep 2026 | Goldman Sachs | BUY | $160.00 |
| 29 Sep 2026 | Scotiabank | BUY | $180.00 |
| 29 Sep 2026 | RBC Capital | HOLD | $150.00 |
| 25 Sep 2026 | BMO Capital | BUY | $170.00 |
| 24 Sep 2026 | UBS | BUY | $175.00 |
No comments yet — be the first to weigh in on MRK.